INTERCEPT PHARMACEUTICALS, INC. Uncategorized Contracts & Agreements
34 Contracts & Agreements
- Description of Securities of the Registrant (Filed With SEC on March 2, 2023)
- Sublicense Agreement, dated May 5, 2022, among Intercept Pharma Europe Ltd. (IPEL), Mercury Pharma, and ICPT Inc (Filed With SEC on August 3, 2022)
- Description of Securities of the Registrant (Filed With SEC on March 2, 2022)
- Description of Securities of the Registrant (Filed With SEC on February 25, 2021)
- Sumitomo Agreement, dated March 29, 2011, between the Registrant and Sumitomo Dainippon Pharma Co., Ltd (Filed With SEC on February 25, 2021)
- Description of Securities of the Registrant (Filed With SEC on February 25, 2020)
- Letter Agreement, dated October 25, 2019, between the Registrant and Sumitomo Dainippon Pharma Co., Ltd (Filed With SEC on February 25, 2020)
- DATED: 7th October 2016 (1) INTERCEPT PHARMA EUROPE LTD and (2) LISA BRIGHT MORRISON (Filed With SEC on March 1, 2017)
- LEGACY YARDS TENANT LP, Landlord TO INTERCEPT PHARMACEUTICALS, INC., Tenant (Filed With SEC on March 1, 2017)
- ONE HUDSON YARDS OWNER LLC, Landlord TO INTERCEPT PHARMACEUTICALS, INC., Tenant (Filed With SEC on March 1, 2017)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. (Filed With SEC on November 9, 2016)
- INVENTION, NON-DISCLOSURE,NON-COMPETITION AND NON-SOLICITATIONAGREEMENT (Filed With SEC on August 9, 2016)
- [Remainder of Page Intentionally Left Blank;Signature Page Follows] (Filed With SEC on August 9, 2016)
- Annex A RELEASEOF CLAIMS1 (Filed With SEC on May 10, 2016)
- DATED 22 January 2016 PERFORMING RIGHT SOCIETY, LIMITED as Landlord and INTERCEPT PHARMA EUROPE LTD as Tenant and INTERCEPT PHARMACEUTICALS, INC as Guarantor UNDERLEASE relating... (Filed With SEC on February 29, 2016)
- MERCK SHARP &DOHME LIMITED (1) and INTERCEPT PHARMACEUTICALS,INC. (2) Underlease relating to Part 1st Floor, 2 St PancrasSquare London 80 Guildhall Street, Bury St Edmunds,... (Filed With SEC on February 25, 2015)
- SECOND AMENDMENT (Filed With SEC on December 2, 2013)
- JAMESTOWN 450 WEST 15TH STREET,L.P., (Filed With SEC on October 21, 2013)
- INTERCEPT PHARMACEUTICALS,INC. (a Delawarecorporation) Shares of CommonStock UNDERWRITINGAGREEMENT (Filed With SEC on June 14, 2013)
- EMPLOYMENTAGREEMENT (Filed With SEC on May 14, 2013)
- EMPLOYMENTAGREEMENT (Filed With SEC on May 14, 2013)
- EMPLOYMENTAGREEMENT (Filed With SEC on May 14, 2013)
- AMENDMENT NO. 1 TO SPONSORED RESEARCH AGREEMENT (Filed With SEC on April 30, 2013)
- EMPLOYMENTAGREEMENT (Filed With SEC on April 1, 2013)
- INVENTION, NON-DISCLOSURE, AND NON-SOLICITATIONAGREEMENT (Filed With SEC on April 1, 2013)
- FIRST AMENDMENT (Filed With SEC on March 22, 2013)
- Additional abbreviations may also be used though notin the above list. (Filed With SEC on September 27, 2012)
- CONSULTINGAGREEMENT (Filed With SEC on September 27, 2012)
- INTERCEPTPHARMACEUTICALS, INC. THIRD amendedand restated stockholders agreement (Filed With SEC on September 4, 2012)
- INVENTION, NON-DISCLOSURE, AND NON-SOLICITATIONAGREEMENT (Filed With SEC on September 4, 2012)
- INVENTION, NON-DISCLOSURE, AND NON-SOLICITATION AGREEMENT (Filed With SEC on September 4, 2012)
- INVENTION, NON-DISCLOSURE,AND NON-SOLICITATION AGREEMENT (Filed With SEC on September 4, 2012)
- SPONSORED RESEARCH AGREEMENT (Filed With SEC on September 4, 2012)
- WITNESSETH (Filed With SEC on September 4, 2012)
